Yuanzhi Liu, Linwei Zhang, Long Wang, Xiaoqin Tang, Shengli Wan, Qianqian Huang, . . . Jianming Wu. (2024). Targeting CD38/ ADP-ribosyl cyclase as a novel therapeutic strategy for identification of three potent agonists for leukopenia treatment. Elsevier.
Chicago Style (17th ed.) CitationYuanzhi Liu, et al. Targeting CD38/ ADP-ribosyl Cyclase as a Novel Therapeutic Strategy for Identification of Three Potent Agonists for Leukopenia Treatment. Elsevier, 2024.
MLA (9th ed.) CitationYuanzhi Liu, et al. Targeting CD38/ ADP-ribosyl Cyclase as a Novel Therapeutic Strategy for Identification of Three Potent Agonists for Leukopenia Treatment. Elsevier, 2024.
Warning: These citations may not always be 100% accurate.